Building the Teams
Behind Tomorrow's Breakthroughs
Life Sciences Moves Fast. Your Hiring Should Too.
Epigen Bio Talent is a life sciences recruitment firm built by senior leaders with decades of combined expertise across rare disease, oncology, and genomics, helping biotechs, biopharma, and advanced therapy companies scale specialized teams in competitive markets. The firm combines high-touch executive search methodology with data-driven talent mapping to solve a critical industry challenge: U.S. biotech companies struggling to hire specialized talent fast enough to meet clinical, regulatory, and commercialization timelines.
By delivering immediate access to scientific and commercial specialists often invisible to traditional recruiting channels, Epigen Bio Talent enables clients to achieve:
- Shorter time-to-hire
- Stronger candidate quality
- Deeper reach into passive talent pools
- Consistent communication and integrity throughout the process
Recruiting at the Frontier of Medicine
Rare Disease
Genomics is transforming healthcare through advances in sequencing, gene editing, and precision medicine, but finding the talent to drive this innovation requires recruiters with deep scientific knowledge and genuine industry connections. The right recruiter speaks your language and understands your science.
Oncology
Oncology is one of the most dynamic sectors in life sciences, with rapid innovation in immunotherapy, cell and gene therapy, and precision medicine creating intense demand for top talent. Finding professionals who understand the complexity of cancer biology and the urgency that patients feel every day requires recruiters with real scientific depth and genuine industry connections.
Genomics/Genetics
Genomics and genetics are evolving at an extraordinary pace, with breakthroughs in whole genome sequencing, gene editing, and multi-omics integration driving unprecedented demand for highly specialized talent. Connecting organizations with professionals who can translate genetic insight into meaningful clinical outcomes requires recruiters who truly speak the language of the genome.
Immunology
Immunology is experiencing remarkable scientific momentum, with advances in targeted biologics, regulatory T-cell therapies, and microbiome research reshaping the treatment of autoimmune and immune-mediated diseases. Finding professionals who understand the intricacies of immune pathways and the challenges of this complex therapeutic area requires recruiters with real scientific depth and genuine industry connections.
Results That Speak for Themselves
We supported a European rare disease company as they launched commercial operations in North America. Given the highly specialized nature of the ultra-rare disease market, our client asked us to focus on only 11 target companies. From an initial shortlist of five, we identified an experienced general manager who had previously led successful commercial start-ups and was uniquely equipped to guide the company’s U.S. expansion.
Partnering with an established rare disease biotech, we conducted a search for a seasoned senior biostatistician. Because biostatistics talent is in exceptionally high demand, this search required a highly tailored and creative approach. Ultimately, we secured a candidate with the depth of expertise and strategic insight our client needed to strengthen their clinical development capabilities.
Working closely with a niche oncology biotechnology company, we identified a CTO capable of elevating the organization’s technical vision. The selected candidate came from a larger, well-established oncology firm and brought hands-on leadership experience that enabled the company to modernize its technology roadmap and scale more effectively.
A growing oncology start-up within the North American innovation hub sought a bioinformatics scientist to expand their research capabilities. We attracted a candidate with a rare blend of cutting-edge academic training and practical entrepreneurial experience, able to bridge scientific rigor with fast-paced biotech adaptability.
A mid-sized, well-established oncology biotech was ready to shift toward a more evidence-based and patient-centric commercial model. We identified a rising sales leader with a visionary mindset and the ability to modernize the company’s commercial strategy while fostering strong cross-functional alignment.
To accelerate its modernization efforts, our client sought a leader who could integrate emerging technologies into traditional life-sciences environments. By targeting forward-thinking technology companies, we identified a candidate with deep digital expertise, strong pharma experience, and the ability to guide the organization through a meaningful shift toward digital excellence.
An immunology company in need of funding and financial restructuring partnered with us to identify a finance leader with strategic depth. After focusing on four innovative immunology biotechs, we placed an executive with public-company experience and a proven record of securing capital, positioning the organization for its next phase of growth.
A start-up immunology company sought a lead scientist who could bring both scientific depth and clear direction to their discovery R&D team. We identified an accomplished researcher with the ideal mix of expertise, leadership, and forward-looking perspective to elevate the organization’s early-stage pipeline.